CDRH’s Shuren Talks MDUFA, Industry’s Premarket Wants, Emerging Technologies, And More In Wide-Ranging Interview
CDRH director Jeff Shuren discussed his 2020 priorities with Medtech Insight at his FDA office in White Oak, MD, on 28 February • Source: Ferdous Al-Faruque